Aldeyra Therapeutics, Inc.

This study tested a new medicine called ADX-629 in 4 adults with moderate alcohol-related hepatitis. The goal was to see if the drug is safe and helps control liver inflammation. Participants agreed to stop drinking alcohol during the trial. The study is complete, but results are…

This early-phase study tested an experimental drug called ADX-2191 in 8 adults with retinitis pigmentosa caused by a specific gene mutation (rhodopsin). Participants received multiple injections into the worse-seeing eye to evaluate safety and any changes in vision. The goal was …

This study tested the safety of an eye drop called reproxalap in 757 adults with dry eye disease. Participants used the drops for up to 12 months, and researchers watched for serious side effects like vision changes or increased eye pressure. The goal was to see if the treatment …

This study tested an eye drop called reproxalap in 131 adults with seasonal allergic conjunctivitis (eye allergies). Participants were exposed to ragweed pollen in a special chamber to see if the drops reduced eye itching and redness compared to a placebo. The goal was to find a …

This study tested a new eye drop called reproxalap (0.25%) in 116 adults with dry eye disease. The goal was to see if it reduces eye discomfort better than a placebo drop. Participants rated their discomfort over 100 minutes in a dry environment. The trial is complete and results…

This study tested an eye drop called reproxalap in 421 adults with dry eye disease. Participants used the drops for up to 6 weeks to see if it reduced eye discomfort compared to a placebo. The goal was to ease symptoms, not cure the condition.